Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease
about
DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable.Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis.Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?What is rheumatoid arthritis? Considering consequences of changed classification criteria.
P2860
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Clinical trials of new drugs f ...... hritis: focus on early disease
@ast
Clinical trials of new drugs f ...... hritis: focus on early disease
@en
Clinical trials of new drugs f ...... hritis: focus on early disease
@nl
type
label
Clinical trials of new drugs f ...... hritis: focus on early disease
@ast
Clinical trials of new drugs f ...... hritis: focus on early disease
@en
Clinical trials of new drugs f ...... hritis: focus on early disease
@nl
prefLabel
Clinical trials of new drugs f ...... hritis: focus on early disease
@ast
Clinical trials of new drugs f ...... hritis: focus on early disease
@en
Clinical trials of new drugs f ...... hritis: focus on early disease
@nl
P2093
P2860
P50
P921
P1476
Clinical trials of new drugs f ...... hritis: focus on early disease
@en
P2093
Christopher J Edwards
Eric C Abadie
Ferdinand Breedveld
Heidi Mäkinen
Thierry Thomas
Tuulikki Sokka-Isler
P2860
P304
P356
10.1136/ANNRHEUMDIS-2016-209429
P407
P50
P5008
P577
2016-07-01T00:00:00Z